Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest BOXER CAPITAL, LLC Stock Portfolio

$2.02Billion– No. of Holdings #59

BOXER CAPITAL, LLC Performance:
2024 Q1: 7.84%YTD: 7.84%2023: 18.84%

Performance for 2024 Q1 is 7.84%, and YTD is 7.84%, and 2023 is 18.84%.

About BOXER CAPITAL, LLC and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Boxer Capital, LLC reported an equity portfolio of $2 Billions as of 31 Mar, 2024.

The top stock holdings of Boxer Capital, LLC are SWTX, CYTK, RVMD. The fund has invested 8.3% of it's portfolio in SPRINGWORKS THERAPEUTICS INC and 7.3% of portfolio in CYTOKINETICS INC.

The fund managers got completely rid off MIRATI THERAPEUTICS INC (MRTX), IMMUNOGEN INC (IMGN) and KARUNA THERAPEUTICS INC (KRTX) stocks. They significantly reduced their stock positions in IOVANCE BIOTHERAPEUTICS INC (IOVA), ARGENX SE (ARGX) and IMMUNOVANT INC (IMVT). Boxer Capital, LLC opened new stock positions in VIKING THERAPEUTICS INC (VKTX), KURA ONCOLOGY INC (KURA) and ALLOGENE THERAPEUTICS INC (ALLO). The fund showed a lot of confidence in some stocks as they added substantially to FATE THERAPEUTICS INC (FATE), NKARTA INC (NKTX) and THIRD HARMONIC BIO INC (THRD).
BOXER CAPITAL, LLC Equity Portfolio Value
Last Reported on: 15 May, 2024

BOXER CAPITAL, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Boxer Capital, LLC made a return of 7.84% in the last quarter. In trailing 12 months, it's portfolio return was 31.47%.

New Buys

Ticker$ Bought
viking therapeutics inc24,600,000
kura oncology inc21,330,000
allogene therapeutics inc17,209,500
sana biotechnology inc15,450,000
poseida therapeutics inc14,275,200
engene holdings inc12,337,900
jasper therapeutics inc10,276,000
boundless bio inc10,136,400

New stocks bought by BOXER CAPITAL, LLC

Additions


Additions to existing portfolio by BOXER CAPITAL, LLC

Reductions

Ticker% Reduced
iovance biotherapeutics inc-46.43
argenx se-37.5
immunovant inc-17.5
kalvista pharmaceuticals inc-3.64

BOXER CAPITAL, LLC reduced stake in above stock

Sold off

Ticker$ Sold
mirati therapeutics inc-188,085,000
immunogen inc-87,793,600
atreca inc-290,708
rain oncology inc-1,382,650
kodiak sciences inc-1,824,000
karuna therapeutics inc-79,127,500

BOXER CAPITAL, LLC got rid off the above stocks

Sector Distribution

Boxer Capital, LLC has about 93.6% of it's holdings in Healthcare sector.

Sector%
Healthcare93.6
Others6.4

Market Cap. Distribution

Boxer Capital, LLC has about 8.1% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
MID-CAP50.9
SMALL-CAP32.4
UNALLOCATED6.4
LARGE-CAP4.2
MEGA-CAP3.9
MICRO-CAP2.3

Stocks belong to which Index?

About 73.7% of the stocks held by Boxer Capital, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
RUSSELL 200073.7
Others26.3
Top 5 Winners (%)%
NUVB
nuvation bio inc
404.2 %
RNA
avidity biosciences inc
136.3 %
VKTX
viking therapeutics inc
126.5 %
TARA
protara therapeutics inc
113.8 %
BDTX
black diamond therapeutics i
80.4 %
Top 5 Winners ($)$
SWTX
springworks therapeutics inc
43.5 M
MRUS
merus n v
33.3 M
RNA
avidity biosciences inc
25.4 M
SRPT
sarepta therapeutics inc
21.5 M
IDYA
ideaya biosciences inc
18.3 M
Top 5 Losers (%)%
AMLX
amylyx pharmaceuticals inc
-82.0 %
PRTA
prothena corp plc
-31.3 %
RLAY
relay therapeutics inc
-24.6 %
IMVT
immunovant inc
-22.0 %
TNGX
tango therapeutics inc
-19.8 %
Top 5 Losers ($)$
CYTK
cytokinetics inc
-28.1 M
AMLX
amylyx pharmaceuticals inc
-19.4 M
TNGX
tango therapeutics inc
-16.1 M
BGNE
beigene ltd
-12.0 M
IMVT
immunovant inc
-9.3 M

BOXER CAPITAL, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of BOXER CAPITAL, LLC

Boxer Capital, LLC has 59 stocks in it's portfolio. About 53.8% of the portfolio is in top 10 stocks. CYTK proved to be the most loss making stock for the portfolio. SWTX was the most profitable stock for Boxer Capital, LLC last quarter.

Last Reported on: 15 May, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions